...
首页> 外文期刊>Technological forecasting and social change >The large grey area between 'bona fide' and 'rogue' stem cell interventions - Ethical acceptability and the need to include local variability
【24h】

The large grey area between 'bona fide' and 'rogue' stem cell interventions - Ethical acceptability and the need to include local variability

机译:“善意”和“流氓”干细胞干预之间的较大灰色区域-伦理上的可接受性以及包括局部变异性的需求

获取原文
获取原文并翻译 | 示例
           

摘要

This article aims to put into perspective the binary opposition between 'scientific' clinical research trials and 'rogue' experimental stem cell therapies, and to show why the ethics criteria used by the dominant science community are not suitable for distinguishing between adequate and inadequate treatments. By focusing on the grey area between clinical stem cell trials and stem cell experimentation, the experimental space where patients, medical professionals and life scientists negotiate for diverging reasons and aims, I show why idealised notions of ethics are not feasible for many stem cell scientists in low- and middle-income countries.
机译:本文旨在透视“科学”临床研究试验和“流氓”实验性干细胞疗法之间的二元对立,并说明为什么占主导地位的科学界所采用的伦理标准不适合区分适当和不足的治疗方法。通过关注临床干细胞试验和干细胞实验之间的灰色区域,患者,医学专业人员和生命科学家出于不同原因和目标进行谈判的实验空间,我展示了为什么理想的伦理学概念对于许多干细胞科学家而言并不可行。中低收入国家。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号